Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors
- 19 November 2010
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 404 (1), 68-73
- https://doi.org/10.1016/j.bbrc.2010.11.064
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Radiation and New Molecular Agents, Part II: Targeting HDAC, HSP90, IGF-1R, PI3K, and RasSeminars in Radiation Oncology, 2005
- Histone Deacetylase Inhibitors Radiosensitize Human Melanoma Cells by Suppressing DNA Repair ActivityClinical Cancer Research, 2005
- Drug Insight: histone deacetylase inhibitors—development of the new targeted anticancer agent suberoylanilide hydroxamic acidNature Clinical Practice Oncology, 2005
- Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic PathwaysScience, 2004
- AcK-knowledge Reversible AcetylationScience's STKE, 2004
- Acetylation of the C Terminus of Ku70 by CBP and PCAF Controls Bax-Mediated ApoptosisMolecular Cell, 2004
- Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline InhibitorJournal of Biological Chemistry, 2002
- Coordination of a Transcriptional Switch by HMGI(Y) AcetylationScience, 2001
- Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2001
- Modulation of the Protein Tyrosine Kinase Activity and Autophosphorylation of the Epidermal Growth Factor Receptor by Its Juxtamembrane RegionArchives of Biochemistry and Biophysics, 1999